AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency-Reference-Cited by-同舟云学术

AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency

Published:2017-09-14 Issue:11 Volume:130 Page:1347-1356
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Kung Charles¹,Hixon Jeff¹,Kosinski Penelope A.¹,Cianchetta Giovanni¹,Histen Gavin¹,Chen Yue¹,Hill Collin¹,Gross Stefan¹,Si Yaguang¹,Johnson Kendall¹,DeLaBarre Byron¹,Luo Zhiyong²,Gu Zhiwei²,Yao Gui²,Tang Huachun²,Fang Cheng²,Xu Yingxia²,Lv Xiaobing²,Biller Scott¹,Su Shin-San Michael¹,Yang Hua¹,Popovici-Muller Janeta¹,Salituro Francesco¹,Silverman Lee¹,Dang Lenny¹

Affiliation:

1. Agios Pharmaceuticals, Inc., Cambridge, MA; and

2. Shanghai ChemPartner Co., Ltd., Shanghai, China

Abstract

Key Points AG-348 is a small-molecule allosteric activator of WT red cell pyruvate kinase as well as mutant enzymes associated with hemolytic anemia. Activity in vitro, in mice, and in red blood cells suggests it may address the underlying molecular pathology in PK deficiency patients.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/130/11/1347/1402486/blood753525.pdf

Reference39 articles.

1. Apropos of 3 new types of hemolytic anemia in children. Infantile pyknocytosis. Familial hemolytic anemia with erythrocytic inclusions and pigmenturia. Anemia caused by pyruvate-kinase deficiency;Germain;Pediatrie,1962

2. Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia;Tanaka;Blood,1962

3. Erythrocyte pyruvate kinase deficiency resulting in congenital nonspherocytic hemolytic anemia;Oski;N Engl J Med,1963

4. Haemolytic anaemia due to pyruvate-kinase deficiency;Brunetti;Lancet,1963

5. Erythrocyte pyruvate kinase deficiency: 2015 status report;Grace;Am J Hematol,2015

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare red cell enzymopathies in the Indian population: A comprehensive review;Pediatric Hematology Oncology Journal;2024-12

2. How We Treat Hemolytic Anemia Due to Pyruvate Kinase Deficiency;Hematology Reports;2024-08-31

3. Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease;Blood Advances;2024-08-27

4. Metabolomics and cellular altered pathways in cancer biology: A review;Journal of Biochemical and Molecular Toxicology;2024-08-15

5. Designing a single-arm phase 2 clinical trial of mitapivat for adult patients with erythrocyte membranopathies (SATISFY): a framework for interventional trials in rare anaemias – pilot study protocol;BMJ Open;2024-07